Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3689784012 | Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3689786014 | Lenograstim 13.4 million unit powder for solution for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Powder for solution for injection | true | Inferred relationship | Some | ||
| Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug) | Is a | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug) | Is a | Product containing lenograstim (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug) | Has unit of presentation | Vial (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator value | 13.4 | false | Inferred relationship | Some | 1 | |
| Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator unit | Million unit | true | Inferred relationship | Some | 1 | |
| Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug) | Has precise active ingredient | Lenograstim (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug) | Count of base of active ingredient | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug) | Has basis of strength substance (attribute) | Lenograstim (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug) | Is a | Product containing only lenograstim in parenteral dose form (medicinal product form) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR